Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
Int J Antimicrob Agents. 2020.
PMID: 32147516
Free PMC article.
No abstract available.